Amrita Krishnan, MD Professor, Department of Hematology and Hematopoietic Cell Transplantation, @cityofhope describes the results of the Phase 1 study investigating CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in patients with relapsed/refractory multiple myeloma.
